Stem Cell Market Update to Be Presented at the 9th Annual New York Stem Cell Summit Print E-mail
By GLOBE NEWSWIRE   
Friday, 10 January 2014 05:00

PHILADELPHIA--RRY Publications LLC today announced that the use of stem cell therapies in 2013 cleared $250 million representing a 30% increase over 2012 shipments and a new record.

Said Robin Young, stem cell industry analyst and host of the New York meeting: "The range and scope of stem cell therapeutic use in the United States continues to grow and evolve and now encompasses a number of new indications. Virtually all of the increases we're seeing are for adult stem cell therapies and, in particular, the use by physicians of both allograft and

autologous stem cell products."

Mr. Young's revised forecast of stem cell commercialization revenues for 2014-2024 will be presented at the February meeting in New York.

The companies, scientists and

Error. Page cannot be displayed. Please contact your service provider for more details. (6)

physicians that are at the forefront of this remarkable increase in stem cell therapeutic use will be presenting at the 9th Annual New York Stem Cell Summit. Listed below is the preliminary lineup of presenters for the 9th Annual Stem Cell Summit.

The Stem Cell Summit, an intensive one-day event, allows attendees to learn about the latest developments in the stem cell marketplace, evaluate the groundbreaking stem cell products physicians are using today, and discover the growing market potential in terms of revenues. For 2014, the Summit will feature 30+ presenters, a research review and

debate session, and a special track on expanding the range of stem cell therapies.

The 9th Annual Stem Cell Summit will take place on Feb. 18, 2014, at the Convene Center in the heart of New York City's Financial District. The preliminary roster of companies featured will include representatives from 2013 presenters and new 2014 presenters.

AllCells, LLC. Lonza Group Ltd.
Athersys, Inc. Mesoblast Limited
BioLife Solutions, Inc. Neostem, Inc.
BioTime, Inc. Neuralstem
Case Western Reserve University NuVasive, Inc.
Celling Biosciences Osiris Therapeutics, Inc.
Cellular Biomedicine Group, Inc. Parcell Laboratories, Inc.
CTI Clinical Trial & Consulting Services Pluristem Therapeutics, Inc.
Cryoport Inc. Progenitor Cell Therapy, LLC
Gamida Cell Ltd. Promethera Biosciences
Histogen, Inc Stem Cell Therapeutics Corp.
INCELL Corporation LLC StemCells Inc.
ISTO Technologies, Inc. TiGenix NV
Lifenet Health Tissue Genesis, Inc. 
 
9th Annual New York Stem Cell Summit Facts at a Glance
   
What: Largest Gathering of Stem Cell Company Executives, Scientists, Investors, and Physicians
   
When: February 18, 2014
   
Where:  Convene Center
  32 Old Slip
  New York City
   
Who: The Stem Cell Summit is organized by RRY Publications LLC
   
Admission: $1,200 through January 2014
  $1,500 Registration (February 1, 2014 – February 18, 2014 and onsite)
   
Information: For more information on presentation or sponsorship opportunities, call Bharathi Kavalipati at 610-260-6462 or send an email to bharathi@ryortho.com
  Additional information, including attendee registration details, is available at www.stemcellsummit.com
CONTACT: Suzanne Kirchner          RRY Publications LLC          501-251-1797          skirchner@ryortho.com



BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BMR:1